Xellia Pharmaceuticals - Ownership and Business Overview

Life ScienceCompany

Xellia Pharmaceuticals Ownership

Who owns Xellia Pharmaceuticals?

Xellia Pharmaceuticals is owned by Novo Holdings A/S. It was acquired on May 21, 2013.

Is Xellia Pharmaceuticals PE-backed?

Yes. Xellia Pharmaceuticals is owned by private equity investor Novo Holdings A/S.

Was Xellia Pharmaceuticals formerly PE-backed?

Yes. Xellia Pharmaceuticals was formerly owned by 1 private investor.

Xellia Pharmaceuticals Business Overview

Where is Xellia Pharmaceuticals headquartered?

Xellia Pharmaceuticals is headquartered in Copenhagen, Denmark.

What sector is Xellia Pharmaceuticals in?

Xellia Pharmaceuticals is a life science company.

When was Xellia Pharmaceuticals founded?

Xellia Pharmaceuticals was founded in 1994.

Life Science M&A Summary in 2013

Out of 60 sectors in the Mergr database, life science ranked 8 in number of deals in 2013. The largest life science acquisition in 2013 was Onyx Pharmaceuticals - which was acquired by Amgen for $10.4B.

Join Mergr to view all 191 acquisitions of life science companies in 2013, including 25 acquisitions by private equity firms, and 166 by strategics.

Xellia Pharmaceuticals

Xellia Pharmaceuticals AS

Dalslandsgade 11,
Copenhagen, 2300
Denmark,
+45 32-64-55-00
www.xellia.com

Xellia Pharmaceuticals is a provider and developer of anti-infective drugs, active pharmaceutical ingredients (API), and final dosage presentation. Its clients include a range of national, multinational, and global pharmaceutical and generic companies. Xellia Pharmaceuticals was formed in 1994 and is based in Copenhagen, Denmark.


Company Summary

SECTOR

Life Science

Established

1994

 Subscribe to unlock this and 201,535
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
1 Week Free Trial Learn More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.5K Private Equity Firms
  • 193K M&A Transactions
  • 197K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for Xellia Pharmaceuticals

Life Science Companies , Denmark Companies

Related Lists for Life Science Companies

Largest Life Science Companies , Acquisitive Life Science Companies , Recently Acquired Life Science Companies , Recently Sold Life Science Companies , Private Life Science Companies , Public Life Science Companies , Acquired Life Science Companies , PE Backed Life Science Companies

Related Lists for Denmark Companies

Largest Denmark Companies , Acquisitive Denmark Companies , Recently Acquired Denmark Companies , Recently Sold Denmark Companies , Private Denmark Companies , Public Denmark Companies , Acquired Denmark Companies , PE Backed Denmark Companies
Mergr

Product

Company

Legal